Migraine during pregnancy: Is it more than a headache?

Nature Reviews Neurology

Volumn 5, Issue 8, 2009, Pages 449-456

  Contag, Stephen A ^a   Mertz, Heather L ^a   Bushnell, Cheryl D ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORPROMAZINE; DIHYDROERGOTAMINE; ERGOT ALKALOID; ERGOT DERIVATIVE; ERGOTAMINE; FOLIC ACID; GADOLINIUM; IBUPROFEN; INDOMETACIN; LABETALOL; METOCLOPRAMIDE; METOPROLOL; NONSTEROID ANTIINFLAMMATORY AGENT; ONDANSETRON; OPIATE; PARACETAMOL; PAROXETINE; PROCHLORPERAZINE; PROPRANOLOL; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TOPIRAMATE; TRIPTAN DERIVATIVE; UNINDEXED DRUG;

ARTERIAL VASOCONSTRICTION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG CHOICE; DRUG EFFICACY; DRUG EXCRETION; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; HEADACHE; HUMAN; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; MIGRAINE; MUSCLE CONTRACTILITY; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STROKE; UTERINE MUSCLE CONTRACTILIY; UTERUS BLOOD FLOW; VASOCONSTRICTION; FEMALE; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION;

DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MIGRAINE DISORDERS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 70350447961     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2009.100     Document Type: Review

References (73)

1. Lipton, R., stewart, W., Diamond, S., Diamond, M. L., reed, M. Prevalence and burden of migraine in the United states: data from the American Migraine study ii. Headache 41, 646-657 (2001).
2. Somerville B. W. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 22, 355-365: 1972
3. Menon, R., Bushnell, C. D. Headache and pregnancy. Neurologist 14, 108-119 (2008).
4. Headache Classification subcommittee of the international Headache society. The international Classification of Headache Disorders: 2nd edition: Cephalalgia 24 Suppl. 1, 9-160: 2004
5. welch, K. M., DAndrea, G., Tepley, N., Barkley, G., ramadan, N. M. The concept of migraine as a state of central neuronal hyperexcitability. Neurol. Clin. 8, 817-828 (1990).
6. rothrock, J. F. "Outside-in" vs "inside-out": revisiting migraines vascular hypothesis. Headache 48, 1409-1410 (2008).
7. silberstein, s. D. Migraine. Lancet 363, 381-391 (2004).
8. Goadsby, P., edvinsson, L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann. Neurol. 33, 48-56 (1993).
9. stang, P. et al. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis risk in Communities study. Neurology 64, 1573-1577 (2005).
10. Kurth, T. et al. Migraine, headache, and the risk of stroke in women. Neurology 64, 1020-1026 (2005).
11. Gupta, V. Silent or non-clinical infarct-like lesions in the posterior circulation territory in migraine: brain hypoperfusion or hyperperfusion? Brain 129, e39 (2006).
12. Calabrese, L. H., Dodick, D. w., schwedt, T. J., Singhal, A. B. Narrative review: reversible cerebral vasoconstriction syndromes. Ann. Intern. Med. 146, 34-44 (2007).
13. Tietjen, G. e. Migraine as a systemic disorder. Neurology 68, 1555-1556 (2007).
14. Lance, J. w., Anthony, M. Some clinical aspects of migraine: a prospective survey of 500 patients. Arch. Neurol. 15, 356-361 (1966).
15. Kelman, L. womens issues of migraine in tertiary care. Headache 44, 2-7 (2004).
16. Marcus, D. A., scharff, L., Turk, D. C. Longitudinal prospective study of headache during pregnancy and postpartum. Headache 39, 625-632 (1999).
17. sances, G. et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 23, 197-205 (2003).
18. scharff, L., Marcus, D. A., Turk, D. C. Headache during pregnancy and in the postpartum: a prospective study. Headache 37, 203-210 (1997).
19. Granella, F. et al. Migraine with aura and reproductive life events: a case control study. Cephalalgia 20, 701-707 (2000).
20. Amir, B. Y. et al. Headaches in women undergoing in vitro fertilization and embryotransfer treatment. Headache 45, 215-219 (2005).
21. Parra, J. et al. Migrainous infarction and clomiphene citrate [spanish]. Rev. Neurol. 42, 572-574 (2006).
22. silberstein, s. Headache and female hormones: what you need to know. Curr. Opin. Neurol. 14, 323-333 (2001).
23. ertresvåg, J. M., Zwart, J. A., Helde, J., Johnsen, H., Bovim, G. Headache and transient focal neurological symptoms during pregnancy, a prospective cohort. Acta Neurol. Scand. 111, 233-237 (2005).
24. Banhidy, F., Acs, N., Horvth-Puh, E., Czeizel, A. Pregnancy complications and delivery outcomes in pregnant women with severe migraine Eur. J. Obstet. Gynecol. Reprod. Biol. 134, 157-163 (2006).
25. Facchinetti, F., Allais, G., DAmico, r., Benedetto, C., Volpe, A. The relationship between headache and pre-eclampsia: a casecontrol study. Eur. J. Obstet. Gynecol. Reprod. Biol. 121, 143-148 (2005).
26. Adeney, K. Risk of pre-eclampsia in relation to maternal history of migraine headaches. J. Matern. Fetal Neonatal Med. 18, 167-172 (2005).
27. Maggioni, F., Alessi, C., Maggino, T., Zanchin, G. Headache during pregnancy. Cephalalgia 17, 765-769 (1997).
28. wainscott, G., volans, G., sullivan, F., Wilkinson, M. The outcome of pregnancy in women suffering from migraine. Postgrad. Med. J. 54, 98-102 (1978).
29. Bushnell, C. D., Jamison, M. G., James, A. Migraines during pregnancy linked to stroke and vascular diseases: Us population based casecontrol study. BMJ 338, b664 (2009).
30. Loder, E. Migraine in pregnancy. Semin. Neurol. 27, 425-433 (2007).
31. singhal, A. B., Bernstein, R. A. Postpartum angiopathy and other cerebral vasoconstriction syndromes. Neurocritic. Care 3, 91-97 (2005).
32. silberstein, s. Practice Parameter: evidencebased guidelines for migraine headache (an evidence-based review): report of the Quality standards subcommittee of the American Academy of Neurology. Neurology 55, 754-762 (2000).
33. Kumar, K. L., Cooney, T. G. Headaches. Med. Clin. North Am. 79, 261-286 (1995).
34. Kent, D. L., Haynor, D. R., Longstreth, W. T., Larson, E. The clinical efficacy of magnetic resonance imaging in neuroimaging. Ann. Intern. Med. 120, 856-871 (1994). (Pubitemid 24140512)
35. Brent, R. Saving lives and changing family histories: appropriate counseling of pregnant women and men and women of reproductive age, concerning the risk of diagnostic radiation exposures during and before pregnancy. Am. J. Obstet. Gynecol. 200, 4-24 (2009).
36. Gorson, R. O. Report No. 054-Medical radiation exposure of pregnant and potentially pregnant women (National Council on radiation Protection and Measurements, Bethesda, MD, 1977).
37. Lin, s. P., Brown, J. J. Mr contrast agents: physical and pharmacologic basics. J. Magn. Reson. Imaging 25, 884-899 (2007).
38. Kanal, E. et al. ACr guidance document for safe Mr practices: 2007. AJR Am. J. Roentgenol. 188, 1447-1474 (2007).
39. Tepel, M. et al. Prevention of radiographiccontrast- agent-induced reductions in renal function by acetylcysteine. N. Engl. J. Med. 343, 180-184 (2000).
40. rao, Q. A., Newhouse, J. H. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 239, 392-397 (2006).
41. webb, J., Thomsen, H., Morcos, s., Members of Contrast Media safety Committee of european society of Urogenital radiology (esUr). The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur. Radiol. 15, 1234-1240 (2005).
42. Cunningham, F. et al. Williams Obstetrics 22nd edn 567-618 (McGraw-Hill Professional, New York, 2001).
43. [No authors listed] report of the National High Blood Pressure education Program working Group on High Blood Pressure in Pregnancy. Am. J. Obstet. Gynecol. 183, s1-s22 (2000).
44. sanchez, s. E., Qiu, C., williams, M. A., Lam, N., Sorensen, T. K. Headaches and migraines are associated with an increased risk of preeclampsia in Peruvian women. Am. J. Hypertens. 21, 360-364 (2008).
45. Adeney, K. L., Williams, M. A. Migraine headaches and pre-eclampsia: an epidemiologic review. Headache 46, 794-803 (2006).
46. Zhou, Y. et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe pre-eclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am. J. Pathol. 160, 1405-1423 (2002).
47. sibai, B. et al. Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia. Am. J. Obstet. Gynecol. 200, e1-8 (2009).
48. welch, K. M. Contemporary concepts of migraine pathogenesis. Neurology 61 (Suppl. 4), s2-s8 (2003).
49. Hayashi, M. et al. Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and preeclampsia. Eur. J. Haematol. 69, 297-302 (2002). (Pubitemid 36005818)
50. wilson, B. J. et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 326, 845-852 (2003).
51. Brown, D. w. et al. Pre-eclampsia and the risk of ischemic stroke among young women: results from the stroke Prevention in Young women study. Stroke 37, 1055-1059 (2006).
52. Fox, A. w., Diamond, M. L., Spierings, E. L. Migraine during pregnancy: options for therapy. CNS Drugs 19, 465-481 (2005).
53. Food and Nutrition Board, institute of Medicine, National Academy of sciences. Dietary reference intakes for thiamine, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. (National Academy Press, washington DC, 1998).
54. Centers for Disease Control (CDC). Use of folic acid for prevention of spina bifida and other neural tube defects-1983-1991. MMWR Morb. Mortal. Wkly Rep. 40, 513-516 (1991).
55. Pitkin, R. M. Folate and neural tube defects. Am. J. Clin. Nutr. 85, s285-s288 (2007).
56. Hunt, s. et al. Topiramate in pregnancy: preliminary experience from the UK epilepsy and Pregnancy register. Neurology 71, 272-276 (2008).
57. Friedman, J. et al. Potential human teratogenicity of frequently prescribed drugs. Obstet. Gynecol. 75, 594-599 (1990).
58. Addis, A., sharabi, s., Bonati, M. Risk classification systems for drug use during pregnancy: are they a reliable source of information? Drug Saf. 23, 245-253 (2000).
59. silberstein, s. D. The pharmacology of ergotamine and dihydroergotamine. Headache 37 (Suppl. 1), s15-s25 (1997).
60. Graham, J. R., Wolff, H. G. Mechanism of migraine headache and action of ergotamine tartrate. Arch. Neurol. Psych. 39, 737-763 (1938).
61. Czeizel, A. Teratogenicity of ergotamine. J. Med. Genet. 26, 69-70 (1989).
62. Hoyer, D. et al. international Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157-203 (1994).
63. Humphrey, P. P. et al. Preclinical studies on the anti-migraine drug, sumatriptan. Eur. Neurol. 31, 282-290 (1991).
64. Moskowitz, M. A. Neurogenic versus vascular mechanism of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol. Sci. 13, 307-311 (1992).
65. Loder, E. Safety of sumatriptan in pregnancy: a review of the data so far. CNS Drugs 17, 1-7 (2003).
66. Fox, A. w., Chambers, C., Anderson, P. evidence-based assessment of pregnancy outcome after sumatriptan exposure. Headache 42, 8-15 (2002).
67. OQuinn, s. et al. Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study. Arch. Gynecol. Obstet. 263, 7-12 (1999).
68. The sumatriptan and Naratriptan Pregnancy registry interim report. 1 January 1996 through 30 April 2004 (GlaxosmithKline Company, wilmington, NC, 2004).
69. Källn, B., Lygner, P. e. Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache 41, 351-356 (2001).
70. Hendricks, S., smith, J., Moore, D., Brown, Z. Oligohydramnios associated with prostaglandin synthetase inhibitors in preterm labour. Br. J. Obstet. Gynaecol. 97, 312-316 (1990).
71. Diener, H., Lampl, C., reimnitz, P., Voelker, M. Aspirin in the treatment of acute migraine attacks. Expert Rev. Neurother. 6, 563-573 (2006).
72. regal, R. E., Billi, J. e., Glazer, H. M. Phenothiazine-induced cholestatic jaundice. Clin. Pharm. 6, 787-794 (1987).
73. Davis, R. L. et al. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol. Drug Saf. 16, 1086-1094 (2007).